Bio B2B 〉 Selective Search Results
Your Selection Setting ：Preclinical Research；
Selective Search Results :
Biotech Companies 11 record(s)；
SINEW PHARMA INC.
Sinew Pharma was established in 2014 to aim at the current world urgent important unmet medical needs. The technology platform was based on the modulation of hepatic metabolic enzymes and genes. Among 6 core products, 2 were developed for the treatment of non-alcoholic steatohepatitis (NASH), 4 for the most widely used analgesics acetaminophen related hepatotoxicity.SNP-610 was approved by USFDA
Taiwan Advance Bio-Pharmaceutical Inc.
Invested by Taiwan Government--the Ministry of Economic Affairs--in 2000, Taiwan Advance Bio-Pharmaceutical Incorporation (TABP) is the first biotechnology company in Taiwan, specializing in the food and feed diagnostic kits. Till now TABP has over 60 product lines, whose range cover most common used chemical compounds such as ractopamine and tetracycline, and a 90% domestic market share. The key features
SOFIVA GENOMICS is an assembly of authoritative physicians and expert consultants in maternal-fetal medicine, cancer medicine, medical genetics, and clinical medicine. We aspire to act as both clinical physicians and research scientists and closely join fundamental medical research and clinical diagnosis together using translational medicine so as serve our mission and value in medical genetics.Our
Henlix Biotech Co., Ltd
Henlix Biotech Inc., an innovative biopharmaceutical company, was co-founded by two American biopharmaceutical veterans, Dr. Scott Liu and Dr. Weidong Jiang in October 2010, in Taiwan and expanded its research site in the San Francisco Bay Area. The company specializes in the discovery and development of innovative monoclonal antibody therapeutics, bi-specific antibodies and antibody drug
Foresee Pharmaceuticals Co., Ltd.
Company ProfileForesee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange. Foresee's R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery platform and derived drug products targeting specialty markets, and its transformative early stage preclinical and clinical NCE programs targeting inflammatory &
SynCore Biotechnology Co., Ltd.
SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutial company focusing on creating values of new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar's experiences which have been accumulated for more than 30 years in R&D, manufacturing
PharmaEngine, Inc. is a biopharmaceutical company established in February 2003 with funding from TTY Biopharm, National Development Fund and Taiwanese venture capital. We are a networked pharma company that operates according to a combination of "No Research Development Only (NRDO)" model and "Networked Pharma" model. Our company is led by Dr. C. Grace Yeh, and supported
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology
Tseng Hsiang Life Science LTD.
Tseng Hsiang Life Science Ltd. is the leading company in Taiwan handling Biotechnology products since 1976 and has 43 years' marketing experiences in the fields of Tissue Culture, Molecular Biology, Immunology & Cell Biology with diverse customers bases in Biomedical research, Biochemistry, Animal science, Cytogenetic, Agricultural technology, Microbiology and Biotec firms. We are
GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
Gwo Xi Company was founded in 2004. We are developing stem cell therapies that have the potential to transform the lives of people with degeneration diseases and rare diseases. Our production platform is fully compliant with medical regulations (Good Tissue Practice, GTP) in Taiwan. We are committed to continuing to develop stem cell therapy technologies and capabilities. From now, Gwo Xi have 3 clinical